Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/07/1999WO1999049862A1 Isoflavones for treating giardiasis and malaria
10/07/1999WO1999049861A1 Deodorant agents for oral use for discharges and method for relieving odor of discharges
10/07/1999WO1999049860A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999WO1999049859A1 Dfmo and sulindac combination in cancer chemoprevention
10/07/1999WO1999049857A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049854A2 Use of dexmedetomidine for icu sedation
10/07/1999WO1999049853A1 Therapeutic system which can be moisture-activated
10/07/1999WO1999049852A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
10/07/1999WO1999049849A1 Liposomal bupivacaine compositions and methods of preparation
10/07/1999WO1999049848A1 Anticancer compositions
10/07/1999WO1999049847A1 Neuroprotective composition
10/07/1999WO1999049845A1 Peroral active agent suspension
10/07/1999WO1999049844A2 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
10/07/1999WO1999049843A1 Solid, quick dissolving cetirizine formulations
10/07/1999WO1999049842A1 Fizzy formulations
10/07/1999WO1999049838A1 Use of retinoic acid activity inhibitors to slow down hair loss
10/07/1999WO1999049837A1 Poly-aminoacid derivatives and their use in compositions for treating keratinous fibres
10/07/1999WO1999049835A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999WO1999049830A2 Antiviral effect of propolis by inhibiting viral nucleic acid polymerases
10/07/1999WO1999049716A2 Method for producing liposomal formulations of active agents by high-pressure homogenisation
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999042501A3 Method for the production of polymers from n-vinyl compounds
10/07/1999WO1999042456A3 Novel compounds and their use as positive ampa receptor modulators
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999037309A9 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
10/07/1999WO1999037292A3 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
10/07/1999WO1999035226B1 Soap bars with a bactericidal capacity and methods of enhancing such capacity
10/07/1999WO1999033453A3 R-procyclidine for treating urinary incontinence
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999WO1999027924A3 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
10/07/1999WO1999018930A3 Pharmaceutical preparations
10/07/1999WO1999017760A3 Fungal or mammalian cell efflux pump inhibitors for enhancing susceptibility of the cell to a drug
10/07/1999WO1999015147A3 Use of alkylmonoglucosides as molecular vectors
10/07/1999DE19914474A1 New peptide aldehyde and boronic acid derivatives are proteinase inhibitors useful for treatment of viral infections, especially hepatitis
10/07/1999DE19910856A1 Strukturiertes Wasser für eine verbesserte Anfeuchtung Structured water for improved wetting
10/07/1999DE19901270A1 Production of beta-1,6-branched beta-1,3-glucan useful as skin anti-aging, depigmenting and healing agent
10/07/1999DE19815411A1 Thermogenesis stimulant comprising moxonidine, useful e.g. for treating hypothermia or promoting weight loss, having no cardiac stimulant side effects
10/07/1999DE19815020A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999DE19814814A1 Aqueous or water-soluble composition containing iminophenazine derivative useful for preparing antimycobacterial, immunosuppressant, antiinflammatory and/or antiviral medicaments
10/07/1999DE19814739A1 Solubilizing agents useful in pharmaceutical, cosmetic and food compositions
10/07/1999DE19814405A1 Neue Porphyrine und ihre Verwendung New porphyrins and their use
10/07/1999DE19814358A1 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn Use of alkyl hydrogen for the treatment of psoriasis, psoriatic arthritis, atopic dermatitis, and Crohn's disease
10/07/1999DE19814257A1 Brauseformulierungen Effervescent formulations
10/07/1999DE19814256A1 Feste, schnellzerfallende Cetirizin-Formulierungen Solid rapidly disintegrating cetirizine formulations
10/07/1999DE19812777A1 Verfahren zur beschleunigten Aufnahme vom Carotinoiden in Serum und Gewebe A method for accelerated uptake of carotenoids in serum and tissue
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2543133A1 Compounds with activity on muscarinic receptors
10/07/1999CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999CA2326774A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999CA2326771A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999CA2326603A1 A drug composition containing sodium pravastatin
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2326576A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999CA2326535A1 Nucleosides with antiviral and anticancer activity
10/07/1999CA2326506A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999CA2326391A1 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999CA2326357A1 Cyclin dependent kinase inhibitors
10/07/1999CA2326166A1 Indole derivatives with antiviral activity
10/07/1999CA2326117A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999CA2325997A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325858A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999CA2325721A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999CA2325521A1 Macrolide lhrh antagonists
10/07/1999CA2325519A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999CA2325080A1 Dfmo and sulindac combination in cancer chemoprevention
10/07/1999CA2324899A1 Use of retinoic acid activity inhibitors to slow down hair loss
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324584A1 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999CA2324444A1 P53-regulated genes
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324302A1 Poly-aminoacid derivatives and their use in compositions for treating keratinous fibres
10/07/1999CA2322203A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999CA2321538A1 Disubstituted pyrazolines and triazolines as factor xa inhibitors
10/07/1999CA2320421A1 Prophylactic drug for prevention of alcoholic gastritis
10/07/1999CA2320260A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/07/1999CA2319551A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999CA2312953A1 Quinolones as serine protease inhibitors
10/07/1999CA2295049A1 Methods to potentiate intravenous estramustine phosphate
10/06/1999EP0947584A1 Loxoprofen-containing preparation for external use
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947578A1 Substance with antiobestic and cumulative visceral fat-reducing actions and use thereof
10/06/1999EP0947523A1 Acyl derivatives of glycosyl-L-ascorbic acid
10/06/1999EP0947522A2 Process for the preparation of oenotheine B from Epilobium Parviflorum
10/06/1999EP0947514A1 Novel phenanethridinium derivatives
10/06/1999EP0947511A1 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
10/06/1999EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999EP0947503A1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours
10/06/1999EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999EP0947198A1 Pharmaceutical preparation containing folic acid and acetylsalicylic acid
10/06/1999EP0947197A1 Method for producing water dispersible sterol formulations
10/06/1999EP0947196A1 Sustained-release prostaglandin i derivative preparation
10/06/1999EP0947195A1 Protective agents for cells constituting nervous system
1 ... 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 6452 6453 ... 7860